PGR and breast carcinoma: Overall, based on ER/PgR expression, HER2 status, and ki-67%, the number and percentages of luminal breast cancers, triple negative (TN) and HER2 enriched cases were 187 (79.5%), 30 (12.8%) and 18 (7.7%), respectively.